U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT07559188) titled 'Proof-of-Concept for a Novel Optical Aperture Contact Lens in Presbyopia and Keratoconus' on Feb. 02.
Brief Summary: The purpose of this clinical study is to evaluate the effectiveness of the NOA lens, a custom-made scleral contact lens developed by Azalea Vision BV, in improving visual quality for individuals with keratoconus and presbyopia.
This clinical study investigates a new lens design featuring a specific central aperture (opening) intended to enhance image quality by increasing depth of focus and reducing optical aberrations. The NOA lens serves as a functional prototype for future "smart lens" technology, specifically the A...